Ceo, Co-Founder
CurrentHoneycomb provides pioneering single-cell biotechnologies for the interconversion of biological and digital information. Our solutions accelerate the promise of immunotherapies for biomedical research, immune-based diagnostics, and quality control of cellular medicines.